Article ; Online: Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19?
2021 Volume 11, Issue 8, Page(s) 1877–1878
Abstract: Cancer is a strong risk factor for severe COVID-19 disease. In this issue ... ...
Abstract | Cancer is a strong risk factor for severe COVID-19 disease. In this issue of |
---|---|
MeSH term(s) | CD4-Positive T-Lymphocytes ; COVID-19 ; Humans ; Immunity ; Neoplasms/drug therapy ; Programmed Cell Death 1 Receptor ; SARS-CoV-2 |
Chemical Substances | Programmed Cell Death 1 Receptor |
Language | English |
Publishing date | 2021-08-03 |
Publishing country | United States |
Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Comment |
ZDB-ID | 2625242-9 |
ISSN | 2159-8290 ; 2159-8274 |
ISSN (online) | 2159-8290 |
ISSN | 2159-8274 |
DOI | 10.1158/2159-8290.CD-21-0613 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6916: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.